Xtandi 40 mg, Filmtabletten

7680672360010 CH-67236 Filmtabletten

Associated product:

XTANDI cpr pell 40 mg 112 pce
Xtandi 40 mg, Filmtabletten
Xtandi 40 mg, Filmtabletten
Xtandi 40 mg, Filmtabletten
1 / 3
google

Article details

Package size
112
Selling units
112
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/10/2025
Summary of Product Characteristics
Français
13/10/2025
Summary of Product Characteristics
Italien
13/10/2025
Patient information leaflet
Allemand
19/12/2024
Patient information leaflet
Français
19/12/2024
Patient information leaflet
Italien
19/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 3137.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2019

Authorization holder

Astellas Pharma AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
67236
Drug name
Xtandi, Filmtabletten
Galenic form
FILM
ATC Code
L02BB04
Authorization status
Z
Dispensing category
B
First authorization
18/09/2019
Authorization expiration date
31/12/9999
IT Number
07.16.2.
Domain
Human medicine
Field of application
Prostatakarzinom

Package details

Description (FR)
XTANDI cpr pell 40 mg 112 pce
Description (DE)
XTANDI Filmtabl 40 mg 112 Stk
Market launch
18/09/2019
Narcotic (BTM)
No

Other package sizes (1)

None
56 TABL
GTIN: None
Not in V1